Photo by nci from unsplash
Antiphospholipid antibodies (aPL) are known to increase the risk of obstetrical complications. However, aPL significance and prevalence in women with late‐onset pregnancy complications (LO‐PC) need further clarification. Click to show full abstract
Antiphospholipid antibodies (aPL) are known to increase the risk of obstetrical complications. However, aPL significance and prevalence in women with late‐onset pregnancy complications (LO‐PC) need further clarification.
Keywords:
risk;
pregnancy complications;
women late;
prevalence antiphospholipid;
antiphospholipid antibodies
Journal Title: Journal of Thrombosis and Haemostasis
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Thrombosis and Haemostasis
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!